Agenus INC Form 4 insider transactions

Garo H Armen, See Remarks and a Director of Agenus Inc, received 1,971,500 shares of common stock on August 10, 2026.

Timothy Wright, a Director of Agenus Inc, received 50,000 shares of common stock on August 5, 2026.

Steven J O'Day, Chief Medical Officer of Agenus Inc, received 100,000 shares of common stock on August 5, 2026.

Susan B Hirsch, a Director of Agenus Inc, received 50,000 shares of common stock on August 5, 2026.

Jennifer Buell, See Remarks and a Director of Agenus Inc, received 200,000 shares of common stock on August 5, 2026.

Garo H Armen, See Remarks and a Director of Agenus Inc, received 4,852 shares of common stock on July 10, 2026.

Agenus Inc. director Thomas L. Harrison acquired 8,547 shares of common stock through a board compensation policy.

Timothy Wright, a Director at Agenus Inc., acquired 2,267.765 Deferred Stock Units on July 1, 2026, under the company's Amended and Restated Directors' Deferred Compensation Plan.

Garo H. Armen, Director and Officer of Agenus Inc., acquired 5,364 shares of common stock valued at $3.03 per share, with salary paid in stock.

Garo H. Armen, Director and Officer of Agenus Inc., received 4,925 shares of common stock valued at $3.30 per share as compensation for his salary.

Agenus Inc. reports that Garo H. Armen, Director and Officer, received 4,644 shares of common stock valued at $3.50 per share as compensation for his salary.

Garo H. Armen, Director and CEO of Agenus Inc., received 4,540 shares of common stock valued at $3.58 per share as payment for his salary for the pay period ending May 15, 2026.

Agenus Inc. CEO Garo H. Armen received 4,233 shares of common stock as compensation for his salary for the period ending May 1, 2026.

Director Susan Hirsch of Agenus Inc. was granted stock options for 105,000 shares.

Jennifer Buell, Director and Officer at Agenus Inc., acquired 305,000 stock options with an exercise price of $3.90.

Steven J. O'Day, Chief Medical Officer of Agenus Inc., reported the acquisition of stock options.

Director Thomas L. Harrison was granted 122,500 stock options by Agenus Inc. on April 24, 2026, as part of the company's equity incentive plan.

Director Timothy Wright of Agenus Inc. was granted 105,000 stock options on April 24, 2026, under the company's equity incentive plan.

Agenus Inc. executive Austin Charette reports the acquisition of stock options, detailing vesting schedules and award conditions.

Garo H. Armen, Director and Officer of Agenus Inc., was granted significant stock options on April 24, 2026, as detailed in a Form 4 filing.

Director Brian Corvese of Agenus Inc. was granted 210,000 stock options with an exercise price of $3.90, vesting one year from the grant date.

Garo H. Armen, Director and CEO of Agenus Inc., received 3,403 shares of common stock valued at $4.79 per share as payment for his salary.

Agenus Inc. director Thomas L. Harrison received 9,228 shares of common stock as compensation under the company's Board Compensation Election Policy.

Garo H. Armen, Director and CEO of Agenus Inc., received 4,629 shares of common stock valued at $3.33 per share as salary compensation.

Agenus Inc.'s Chairman and CEO, Garo H. Armen, elected to receive his salary in common stock, acquiring 3,983 shares at $3.71 each.

Agenus Inc.'s Chairman and CEO, Garo H. Armen, increased his direct beneficial ownership by 4,829 shares through a stock-for-salary arrangement.

Agenus Inc.'s Chairman and CEO, Garo H. Armen, received 5,027 shares of common stock valued at $2.94 per share as salary, increasing his direct and indirect beneficial ownership.

Agenus Inc. CEO Garo H. Armen elected to receive his salary in common stock, acquiring 4,562 shares at $3.24 each.

Agenus Inc. CEO Garo H. Armen acquired 3,780 shares of common stock at $3.91 per share as part of his salary, opting for equity in lieu of cash.

Agenus Inc. Director Timothy Wright acquired 2,040.576 deferred stock units as part of a compensation plan, increasing his total beneficial ownership to 23,913.006 units.